Trinity Biotech (TRIB) Shares Outstanding (2009 - 2025)

Trinity Biotech (TRIB) has reported Shares Outstanding (Entity) for 12 consecutive years, with $619189.0 the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 3.43% year-over-year to $619189.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $619189.0 (up 3.43% YoY) and the FY2025 annual result came in at $619189.0, up 3.43% from the prior year.
• Shares Outstanding (Entity) climbed to $619189.0 in Q4 2025 per TRIB's latest filing, from $598656.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for TRIB reached as high as $619189.0 in Q4 2025 and fell as low as $139345.0 in Q4 2021.
• A 5-year average of $334020.9 and a median of $255166.0 in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) changed 0.0% — and 2024, when it jumped 134.61%.
• Year by year, Shares Outstanding (Entity) stood at $139345.0 in 2021, then jumped by 61.4% to $224899.0 in 2022, then rose by 13.46% to $255166.0 in 2023, then soared by 134.61% to $598656.0 in 2024, then gained by 3.43% to $619189.0 in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $619189.0, $598656.0, and $305627.0 for Q4 2025, Q4 2024, and Q2 2024 respectively.